Alain Gratet

586 total citations
7 papers, 43 citations indexed

About

Alain Gratet is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Alain Gratet has authored 7 papers receiving a total of 43 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Cancer Research. Recurrent topics in Alain Gratet's work include Pancreatic and Hepatic Oncology Research (3 papers), Cancer Genomics and Diagnostics (3 papers) and BRCA gene mutations in cancer (2 papers). Alain Gratet is often cited by papers focused on Pancreatic and Hepatic Oncology Research (3 papers), Cancer Genomics and Diagnostics (3 papers) and BRCA gene mutations in cancer (2 papers). Alain Gratet collaborates with scholars based in France, Austria and Finland. Alain Gratet's co-authors include Sakari Hietanen, Laurent Mineur, Eva María Guerra Alia, Christelle de la Fouchardière, Carlos Gomez‐Roca, Florence Mary, J. Selves, Hiroyuki Yoshida, Renaud Sabatier and Frédérique Rousseau and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Cancer.

In The Last Decade

Alain Gratet

6 papers receiving 42 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alain Gratet France 3 23 16 11 9 9 7 43
Sabela Recalde Spain 5 41 1.8× 22 1.4× 9 0.8× 9 1.0× 10 1.1× 14 58
Viola Heinzelmann Switzerland 4 22 1.0× 9 0.6× 11 1.0× 13 1.4× 3 0.3× 9 67
Tripti Kumar United States 3 17 0.7× 10 0.6× 17 1.5× 9 1.0× 3 0.3× 9 50
Yiu-Keung Lau United States 4 29 1.3× 20 1.3× 6 0.5× 4 0.4× 4 0.4× 10 53
Saad Tahir United Kingdom 4 23 1.0× 10 0.6× 5 0.5× 3 0.3× 3 0.3× 4 29
Joanne Hornbuckle United Kingdom 3 47 2.0× 18 1.1× 5 0.5× 7 0.8× 18 2.0× 6 50
Andrew Ling United States 5 11 0.5× 33 2.1× 18 1.6× 26 2.9× 11 1.2× 6 74
Wanqing Chen China 5 25 1.1× 10 0.6× 30 2.7× 6 0.7× 18 2.0× 7 77
Kenneth B. Blankstein United States 4 26 1.1× 31 1.9× 8 0.7× 7 0.8× 7 0.8× 7 58
Yehia I. Abugabal United States 3 24 1.0× 13 0.8× 15 1.4× 8 0.9× 46 5.1× 12 80

Countries citing papers authored by Alain Gratet

Since Specialization
Citations

This map shows the geographic impact of Alain Gratet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alain Gratet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alain Gratet more than expected).

Fields of papers citing papers by Alain Gratet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alain Gratet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alain Gratet. The network helps show where Alain Gratet may publish in the future.

Co-authorship network of co-authors of Alain Gratet

This figure shows the co-authorship network connecting the top 25 collaborators of Alain Gratet. A scholar is included among the top collaborators of Alain Gratet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alain Gratet. Alain Gratet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Sabatier, Renaud, Frédérique Rousseau, Florence Joly, et al.. (2022). Efficacy and safety of maintenance olaparib and bevacizumab in ovarian cancer patients aged ≥65 years from the PAOLA-1/ENGOT-ov25 trial. European Journal of Cancer. 181. 42–52. 13 indexed citations
2.
Sabatier, Renaud, Frédérique Rousseau, Florence Joly, et al.. (2021). 739P Efficacy and safety of maintenance olaparib and bevacizumab (bev) in ovarian cancer (OC) patients (pts) aged ≥65 years (y) from the PAOLA-1/ENGOT-ov25 first-line trial. Annals of Oncology. 32. S737–S738. 1 indexed citations
3.
Aparicio, Thomas, Nathalie Cozic, Christelle de la Fouchardière, et al.. (2021). The Activity of Crizotinib in Chemo-Refractory MET-Amplified Esophageal and Gastric Adenocarcinomas: Results from the AcSé-Crizotinib Program. Targeted Oncology. 16(3). 381–388. 20 indexed citations
5.
Aparicio, Thomas, Nathalie Cozic, Christelle de la Fouchardière, et al.. (2018). The activity of crizotinib in chemo-refractory MET-amplified esogastric adenocarcinomas: Results from the AcSé-crizotinib program.. Journal of Clinical Oncology. 36(15_suppl). 4054–4054. 1 indexed citations
6.
Taı̈eb, Julien, Jean–Marc Phelip, Yves Rinaldi, et al.. (2018). Exploratory analyses of 400 patients enrolled in 2 FFCD trials of first line treatment for metastatic pancreatic cancer. Annals of Oncology. 29. viii244–viii244. 1 indexed citations
7.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026